Mass spectrometry recently emerged as a valuable technique for proteogenomic annotations that improve on the state-of-the art in predicting genes and other features. However, previous proteogenomic approaches were limited to a single genome and did not take advantage of analyzing mass spectrometry data from multiple genomes at once. We show that such comparative proteogenomics approach (similarly to comparative genomics approaches) allows one to address the problems that remained beyond the reach of the traditional "single proteome" approach in mass-spectrometry. In particular, we show how comparative proteogenomics addresses the notoriously difficult problem of "one-hit-wonders" in proteomics and improves on the existing gene prediction tools in genomics.
Introduction
Since the sequencing of the first genome, H. influenzae [1] in 1995, the number of sequenced genomes has been rising sharply. Every sequencing project is followed by annotation of the genome to identify genes, pathways, etc. Comparative genomics analysis of multiple genomes has emerged as one of the key approaches for discovery of such genomic elements that greatly improves on existing annotation tools [2, 3, 4] . Another recent development is the application of tandem mass spectrometry (MS/MS) for genomic annotations [5, 6, 7, 8, 9, 10] . Such proteogenomic approaches further improve gene predictions and allow one to address problems that remained beyond the reach of both traditional gene prediction tools and comparative genomics. We recently developed MS-Genome software for automated proteogenomic annotation of bacterial genomes [6] and applied it for improving annotation of Shewanella oneidensis MR-1, a model bacterium for studies of bioremediation and metal reduction. However, the synergy between MS/MS data from different species was never explored in the past. We argue that such comparative proteogenomics analysis sheds new light on the annotations of both genomes and proteomes.
Similar to Expressed Sequence Tags (EST) studies, mass spectrometry experiments generate Expressed Protein Tags (EPT) that provide valuable information about expressed proteins. However, while there 100s of studies on using ESTs for genome annotation, EPT studies are still in infancy. This is unfortunate since EPTs may provide some advantages over ESTS and are easy to generate. In particular, in difference from ESTs, EPTs are relatively uniformly distributed along the protein length and provide information about the translational starts and proteolytic events (e.g., signal peptides). Also, EPTs may be less affected by splicing artifacts (like transplicing) and sequencing errors. However, some EPTs may represent errors in peptide identifications (and are thus completely wrong) making it non-trivial to transform the existing EST approaches into the EPT domain.
While recent high-throughput MS/MS studies generated large spectral datasets for many related species, it remains unclear how to utilize these datasets across various genomes. In this study, we analyze MS/MS datasets for three Shewanella bacteria representing multiple growth conditions: Shewanella oneidensis MR-1 (≈14.5 million spectra), Shewanella frigidimarina (≈ 0.955 million spectra) and Shewanella putrefaciens CN-32 (≈ 0.768 million spectra). These datasets provide an opportunity to analyze expressed proteomes across these bacteria (henceforth referred to as So, Sf and Sp respectively). In addition to predicting new genes and finding errors in existing annotations, we show that MS/MS data helps to identify programmed frameshifts (as well as sequencing errors), a difficult problem in genomics. Drawing parallels from gene microarray platforms, we use mass spectrometry based protein expression data to analyze the conserved and differentially expressed pathways across these species. We also show that comparative analysis of peptides across species is helpful in resolving the notoriously difficult problem of "one-hit-wonders" in proteomics. Our compartaive proteogenomics software is available at http://peptide.ucsd.edu/.
Methods

Peptide Identification
Peptide identification in So was described in the earlier study [6] . We use InsPecT [11] to search the spectra of each species against a database containing the six-frame translation of the genome along with common contaminants and a decoy database of the same size. InsPecT score threshold is selected for each case to limit the number of identification on the decoy database to at most 5% of the number of identifications on the target database. Note that we use a decoy database of the size of the six-frame translation of the genome, almost 7-times larger than the total length of proteins; using a decoy database of the size of the proteome (a common practice in the proteomics community) will result in false discovery rate below 1%. InsPecT software (July, 2007 version) produced 36,914 peptides in So, 27,605 peptides in Sf and 26,625 peptides in Sp. At the same time it produced 2,351, 3,159 and 1,676 peptides in So, Sf, Sp correspondingly that do not match the annotated proteins in these genomes. We demonstrate that coordinated mapping of these peptides (that are usually discarded as false identifications) represents valuable information for improving genome annotations.
Expression analysis of GO categories
In order to provide a functional characterization of protein expression, we analyze the expression at the level of Gene Ontology(GO) [12] classes. Note that, in difference from traditional array studies, we consider a binary notion of expression (a protein is considered expressed if it is identified by two or more peptides). We use the Protein Function Prediction (PFP) software [13] to functionally annotate all proteins with GO categories. This provides us a pathway level annotation of proteins rather than the specific function of every protein. The annotated proteins are clustered according to the Biological Process branch of the GO annotation using Bingo from Cytoscape [14] . The statistical significance of over-representation or under-representation of expressed proteins in each GO category is assessed using the Fisher's exact test. The p-values for each GO category in the three organisms are provided in Supplementary Table S1-A.
Analyzing late start codons
We describe an algorithm for predicting "late" start codons, i.e., the (correct) start codons that are located downstream of the wrongly annotated start codons. While a late start codon implies a "missing" peptide in the beginning of the protein (between the wrongly annotated and correct start codons), such missing peptides can also be caused by low peptide detectability [15] or may simply represent signal peptides. However, non-covered peptides (non-tryptic peptides with no upstream coverage, see [6] for more details) in the beginning of the protein, that cannot be explained by the signal peptide consensus sequence, point to late start codons. There are 36 cases of N-terminal-most non-covered peptides in So, within 30 residues of the start. Conspicuously, many of them either begin with ATG start codons or start immediately after a start codon (as in the case of N-terminal Methionine cleavage, see [6] ). If all these peptides were artifacts, the distribution of the codons for amino acids at positions 1 (where the observed peptide begins) and -1 (corresponding to N-terminal Methionine cleavage) in these peptides would be somewhat uniform with average 36/61 ≈ 0.6 peptides per codon. Instead, we see a non-uniform distribution at position -1 with a sharp peak at ATG (standard Methionine start codon) and over-representation of other start codons (TTG and GTG). We thus argue that all these cases cannot be artifacts (such as degradation products or incorrect peptide identifications).
To exclude signal peptides from consideration, we consider only non-covered peptides located within a distance of 18aa or less from the start of the protein (signal peptides are typically longer than 18 aa). 41, 25 and 18 candidates are observed in So, Sf and Sp respectively. Comparative analysis of the three Shewanella species is subsequently performed to validate these candidates for late start codons.
Correlated Peptides
Traditional MS/MS analysis is focused on identification of proteins and is less concerned with the question which peptides in a protein are observed or not observed. In this study, we utilize the availability of proteomic data from related species to analyze the expression of peptides at orthologous positions. In a typical mass spectrometry experiment, some peptides with low detectability are always missed, resulting in a highly non-uniform protein coverage by identified peptides [16, 15] . For example, while most ribosomal proteins in So have high coverage (above 50%), a few have low coverage and one of them does not have any identified peptides.
All identified peptides in shared genes were mapped to the alignment of the orthologs to get their coordinates with respect to the alignment. This provides a uniform reference scale to compare the positions of observed peptides between the orthologous proteins in the three species, as individual proteins may have different lengths. Peptides identified by MS/MS in two species are called correlated peptides if they are observed in the same position in the protein alignment or one of them spans another. In other words, if one peptide is located at positions (start 1 , end 1 ) in the alignment, and the other peptide at (start 2 , end 2 ), then peptides are
Results
Multiple Shewanella Genomes
The three Shewanella species used in this study were recently sequenced, So [17] containing 5,131,416 base pairs (one chromosome and one plasmid) being the first one. Subsequently, Sf and Sp genomes have been sequenced (4,845,257 and 4,649,325 base pairs respectively).
The protein orthology assignments across different Shewanella species were prepared using Inparanoid [18] , subsequently aligned by Muscle [19] (data courtesy of LeeAnn McCue and Margie Romine at PNNL, unpublished result). Figure 1 (a) shows the numbers of orthologs shared by different Shewanella species. While 2590 genes have orthologs in all three species (we call such triplets "shared genes"), for some proteins, orthologs were found in only one other species, and in many cases (for example, 1715 in So) in none. The shared genes are used for comparative analysis in this study.
Protein Identification
Based on the peptides identified from InsPecT searches (see Methods), expression of 40%-45% proteins is confirmed in each species. Table 1 provides the number of annotated genes and our protein identifications. Interestingly, the fraction of expressed proteins among the shared genes is much higher, at ≈ 60%. This hints a correlation between protein expression and sequence conservation, in agreement with the observations made in [6] . For each species, the total number of genes, the number of genes confirmed as expressed proteins by two or more peptides, and number of genes with only one peptide hit are reported. The numbers in the parentheses represent the number of shared genes, out of 2590 in total, that are present in the corresponding list of genes.
Resolving One-Hit-Wonders
There are 1138 shared genes that are expressed in all three species (see Figure 1 (b)). However, in accordance with the Proteomics Publication Guidelines [20, 21] , we require at least two peptides to consider a protein as expressed. Since almost every analysis of MS/MS datasets reveals a large number of proteins with a single identified peptide (one-hit-wonders), it leads to a significant reduction in the number of identified proteins (single-hit-wonders represent 20, 31 and 28 percent of all identified proteins in So, Sp and Sf respectively). For example, there are 432 such proteins in So that cannot be reported as reliable identifications. While many of them indeed represent expressed proteins it is not clear how to separate them from erroneous peptide identifications [6] . Below we explore the use of comparative analysis across species to reliably select the expressed proteins among the one-hit-wonders.
For each shared gene, we define an expression signature with three values that represents the number of peptide identifications in the three species. The value is 2 if the expression is confirmed by 2 or more peptides, 1 if only 1 peptide is observed, and 0 for no peptides. For example, the signature (0, 1, 2) for a shared gene represents no peptide identification in So, 1 peptide identification in Sp and confirmed expression with 2 or more peptides in Sf. There are 27 possible distinct expression signatures that such a vector may take for a shared gene. We combine these into 10 position independent values, such that (2, 1, 1) is considered the same as (1, 1, 2)) or (1, 2, 1). Table 2 shows the frequency of these 10 expression signatures among the 2,590 shared genes. We argue that a one-hit-wonder can be trusted if its orthologs in other two species also have at least one peptide hit. Such genes are readily identified as having expression signature (1, 1, 1), (1, 1, 2) or (1, 2, 2) . This approach provides extra evidence for the expression of 3 × 11 + 2 × 64 + 208 = 369 one-hit-wonders in total in the three species.
Expression Signature (ES) (0, 0, 0) (0, 0, 1) (0, 0, 2) (0, 1, 1) (0, While orthologous one-hit-wonders are themselves a strong indicator for protein expression, peptides identified at the same orthologous positions (correlated peptides) in different species provide an overwhelming evidence that the proteins are expressed . Since the probability that it happens by chance is extremely small, we now dig deeper into analysis of the orthologous one-hit-wonders and demonstrate that they often have correlated peptides. Figure 2 shows the example of a shared gene (annotated as hypothetical lipoprotein) that has only 1 identified peptide in each organism. However it turns out that these peptides, in spite of being slightly different from each other in their sequences, are located at the same position in the alignment of the orthologs. Thus we argue that these proteins should be considered as expressed and re-annotated to remove the term "hypothetical" from their annotations. One reason for observing only a single peptide from a protein is the relatively few number (one in some cases) of detectable peptides in a protein. However, if this is the case, the same peptides should be observed from the orthologous protein in closely related species. We thus check if the only peptide observed in a protein is correlated across the three species. If the peptide identification is spurious, it is very unlikely that the peptide will be at the same position as the observed peptides in its orthologs. Interestingly, we find 54 out of 432 one-hit-wonders in So having a correlated peptide in at least one of the other two species, providing strong evidence for the expression of these proteins. Similarly, 51 and 82 one-hit-wonders in Sf and Sp can be resolved as expressed based on correlated peptides. We further argue that mutations in correlated peptides provide valuable data for studies of peptide detectability (see Supplement S4).
Expression of pathways
Our previous study [6] demonstrated the use of MS-based protein identification to analyze the expression of pathways or functional categories. Having proteomic data for three species now allows us to compare the expression of pathways and identify which pathways are conserved or differentially expressed across these species. While there are several levels and categorizations to represent pathways, we use Gene Ontology (GO) in this study because of its community-wide acceptance and availability of supporting tools.
As described in the Methods, we identify the GO categories that are significantly overrepresented or under-represented among the expressed proteins. Supplementary Table S1 -B(a) shows the GO categories that are enriched in all of the three species. Expectedly, this list is dominated by metabolism related pathways that are important for the survival of a cell. Supplementary Table S1-B(b) specifies GO categories that are under-represented in the three organisms, and includes some regulation and response related pathways, which may not be utilized under the laboratory culture conditions. The GO categories that are enriched in one organism but under-represented in the other are listed in Supplementary Table S1-B(c), and are mostly related to biosynthesis or metabolism of certain types of compounds, providing potentially useful information regarding the physiological differences between these species.
Correcting Start Sites
Peptides that match the genome in the non protein-coding region upstream to a gene, within 200 bp distance, are considered candidates for early start sites. These are cases of mis-annotated genes that are shortened at their N-terminus. Cases with stop codons between the peptide and the gene start site are discarded. To avoid spurious candidates from incorrect peptide identifications, we consider a peptide only if there is another identified peptide in the same reading frame within 200 bp [6] . The starting position of the peptide (call it position X) does not necessarily correspond to the actual start site of the gene, but only tells that the actual start should be further upstream to X.
To verify early start sites and determine their exact positions, these genes were searched against proteins in 10 other Shewanella strains, and position X for each candidate was compared to the start site of the aligned homolog. These strains included Shewanella loihica PV-4, S. baltica OS155, S. amazonensis SB2B, S. sp. W3-18-1, S. denitrificans OS217, S. sp. ANA-3, S. sp MR-4 and S. sp. MR-7, besides the other two from So, Sf and Sp (leaving the one which the candidate gene belongs to). If the start site of homolog aligned to a particular position equal to or upstream of position X, then this new position was considered to be putative early start site. The most frequent (supported by maximum number of homologs) of these putative starts is chosen as the new start site for the gene.
The list of early start site candidates is provided in Supplementary Table S2-A. 24 among 39 such candidates in So are assigned new start sites based on the comparative analysis mentioned above. Notably, 19 of these early start sites have the expected ATG, GTG or TTG start codons, indicating that these automatically predicted start sites are indeed reliable. 3 and 5 early start sites are identified in Sp and Sf respectively. Interestingly, four of the candidate genes with early start sites are observed in more than one organisms providing further support that these genes have been currently assigned incorrect start sites. These include ligA (So and Sp), ilvg (So and Sp), pcnB in (So and Sf) and infC (So, Sp and Sf).
As described in the Methods, candidates for late start sites were generated using evidence from non-covered peptides. Such instances indicated a potential late start site either at the beginning of the non-covered peptide (call it position X) or, if N-terminal cleavage occurred, one position upstream (X − 1). The sequences of these candidate genes are aligned to the proteins in 9 other Shewanella strains. Each instance where the start of a protein in the other strains aligns to the potential late start site (beginning at position X or X − 1) is considered as confirmed by comparative genomics.
Supplementary Table S2 -B summarizes these cases in each of the three organisms. In So, 6 out of 41 late start candidates are confirmed, four of which start with ATG codon and one with GTG. Similarly, 13 out of 25 candidates are confirmed in Sf, and 6 among the 18 are confirmed in Sp. The table also shows that the majority of these candidates have N-terminal methionine cleavage in the observed peptide. We find comparative proteomic evidence for one case where the late start site (10 amino acids downstream of the annotated start site) is conserved in the orthologs (ATP-dependent Clp protease, proteolytic subunit ClpP) between So (SO 1794) and Sp (CN32 1490). However, we note that this site is also found in our analysis of conserved proteolytic sites (below). While it is unclear whether this peptide corresponds to the late start site or a proteolytic event, it clearly represents a real non-tryptic peptide, as opposed to an incorrect identification. only peptide is observed out of frame at one of the ends. Case C: one peptide is seen out of frame with in-frame peptides on both sides.
Identification of programmed frameshifts and sequencing errors
A frameshift occurs when a ribosome skips one or more nucleotides in an mRNA sequence, thereby changing the reading frame to produce a different protein sequence from the original frame. In programmed frameshifts, this phenomenon is built into the translational machinery [22] . Secondary RNA structures such as pseudoknots are often responsible for the ribosomal pause and resulting frameshift [23] . While many efforts went into frameshift detection [24, 25, 26, 27, 28] , accurate detection of frameshifts remains an unsolved problem. Mass spectrometry, on the other hand, provides experimental evidence for the actual translation products (proteins) and allows one to to detect the frameshifts. The presence of peptides from two different reading frames within the region of a predicted gene may represent: (1) an incorrect peptide identification, (2) an insertion/deletion sequencing error, (3) overlapping genes in different frames, or (4) a programmed frameshift. We demonstrate the application of comparative approaches for distinguishing between these possibilities.
All identified peptides are mapped to the translated frames of the genome and compared with the annotated gene coordinates to determine alternate peptide reading frames in the DNA region of a single gene. As depicted in Figure 3 , three types of cases are typically seen. In case A, multiple peptides are observed in two different frames (only one of them being the annotated frame of the gene) in non-overlapping regions. In case B, only one peptide is observed in an alternative frame at one of the ends, while in case C, one peptide is seen out of frame with inframe peptides on both sides. We postpone the discussion of case C since in this case incorrect peptide identifications or overlapping genes are more likely explanations than a frameshift. Case A provides the most reliable evidence of a programmed frameshift since presence of multiple peptides in the same region greatly reduces the probability that these peptide identifications are spurious. The remaining case B, with only one peptide, is ambiguous and may represent either frameshifts or incorrect peptide identifications, or overlapping genes. We exploit the Figure 5 : An example of a programmed frameshift. The nucleotide sequence for gene SO 0991 is shown in red, the amino acid sequence of the corresponding protein is shown in green, and the amino acid sequences of the three translated frames are shown in black. This gene has been correctly annotated in TIGR, and our predicted peptides in both the original frame and the alternative frame match the protein sequence.
sequences of multiple Shewanella strains to find comparative evidence for putative frameshifts in these cases. Protein sequence from the original frame of the gene, as well as sequence from the alternate frame implied by the identified peptides, is compared against the other Shewanella strains using BLAST [29] . Good matches to the alternate-frame sequence and no matches to the gene-frame sequence provide additional evidence for a frameshift. We note that some apparent frameshifts may be caused by sequencing errors (indels) in the genome sequence when a certain number (not multiple of 3) of bases are erroneously added to or deleted from the sequence. To identify such sequencing errors, we take the nucleotide sequence of the region where frameshift occurs (region between the observed in-frame and alternate-frame peptides) and generate ClustalW [30] multiple sequence alignment with the orthologous region in the other strains. A sequencing error is visible in this alignment as an indel in the original sequence (see Figure 4) . Figure 5 shows an example of a programmed frameshift detected through this approach.
We identified 19 frameshift candidates in So conforming to case A (Supplementary Table S3-A). All these candidate frameshifts were verified with significant E-values. Eight of these instances turned out to be sequencing errors, and three genes are putative programmed frameshifts: SO0991 (+1), SO4538 (-1), and SO4115 (-1). SO0991 ( Figure 5 ) is related to the peptide chain release factor 2 in E. coli, that is known to undergo a programmed frameshift [31] .
221 frameshift candidates were identified conforming to case B but no frameshifts could be verified in Sp or Sf. Three genes conformed to case A in Sp but they failed the orthology test and the alternate frames were riddled with stop codons (Supplementary Table S3-B) . This may be attributed to the relatively small number of spectra for these two species (less than a million spectra each) as compared to 14.5 million spectra for So. 
Proteolytic events
In Gupta et al, 2007 [6] , we demonstrated the use of genome scale MS/MS dataset for identification of N-terminal proteolytic events such as N-terminal methionine cleavage and signal peptide cleavage. An in vivo proteolytic event can be observed as a non-tryptic peptide (assuming the proteolytic enzyme does not have the same specificity as trypsin). However, nontryptic peptides may also be observed due to other reasons, such as degradation of tryptic peptides or incorrect peptide identifications. In [32] , we showed that the likelihood of incorrect peptide identifications can be reduced drastically (to less than 0.1%) by considering only doubly-confirmed cleavages and filtering out possible degradation products.
By applying the same filtering approach as in [32] and removing the cuts explained by the trypsin specificity, we obtain 494, 155 and 85 putative proteolytic sites in So, Sp and Sf respectively. To check whether some of these sites are conserved between multiple organisms, we map them on the alignment of orthologous protein. 37 proteolytic sites are found conserved between two or more organisms (see Table 3 ). This is a significantly larger number of conserved sites than expected by chance. For example, with proteomes of length ≈ 1 million amino acids each, the expected number of sites conserved by chance between Sp and Sf is less than (85/10 6 ) × (155/10 6 ) × 10 6 ≈ 0.01, but we observe 14. One may further challenge that these cleavages may be an artifact of in-vitro peptide degradations, and that these peptides may be over-represented in proteins containing multiple peptides. In this case, the statistical argument above must to be applied to the set of these highly-expressed proteins rather than to all proteins. To check this, we took proteins with 10 or more peptides (703 proteins in Sp, 753 in Sf) with total length close to 300 thousand aa in each organism, and 154 and 75 putative proteolytic sites in Sp and Sf respectively. All 14 sites conserved between Sp and Sf belong to these highly-expressed proteins. The expected number of sites conserved by chance in these proteins is (75/300000) × (154/300000) × 300000 ≈ 0.04, still much smaller than the observed 14 sites. Thus we argue that the conserved sites reported here cannot be results of non-specific degradations.
We note that many of these sites are located within peptide ladders (multiple overlapping peptides) which also raises the possibility that these cleavage sites may be a result of peptide degradation (see example in Figure 6 ). However, carefully looking into these ladders, we see that they are more likely a union of two peptide ladders, one coming from the proteolysed and the other from the unproteolysed protein product. This is supported by high spectral counts for the peptides around the cleavage site in many cases, given that one expects much lower spectral counts (usually 1) for degraded peptides as compared to the tryptic (un-degraded) peptide in a ladder. For example, the peptide LVNTGWTGGPHGIGK that supports the predicted cleavage site in Figure 6 has a spectral count of 103, even higher than the spectral counts of the covering tryptic peptides. Based on this and the statistical evidence shown above, we expect that our conserved cleavage sites represent in-vivo proteolytic events. Since the knowledge of proteolytic events in bacteria is still very limited at genomic scale, we are not able to provide additional supporting information about the origin or relevance of each predicted site individually; but we make the data available for comparison with future studies. Supplement S5 provides peptides ladders for all the 37 identified sites (see Instructions.txt in the supplement archive for details).
Note that here we used the traditional rules for trypsin specificity, allowing a cut after arginine or lysine but not before proline. Interestingly, 5 of the 37 conserved sites happen to be cuts between arginine and proline, indicating that these may be a result of trypsin digestion, further supporting our claim in [32] that the cuts after arginine and lysine followed by a proline should be considered tryptic. Other 8 sites are signal peptide cleavages also predicted by SignalP [33] providing additional support that the found sites represent proteolytic events rather than statistical artifacts.
Discussion
Shewanella oneidensis MR-1 is among the most carefully annotated bacterial genomes: gene predictions in this genome were studied in two papers [34, 35] and are being continuously improved by the Shewanella Federation http://www.shewanella.org/. Significant manual effort (that took into account comparative genomics evidence) also went into the annotation of Shewanella frigidimarina and Shewanella putrefaciens CN-32 at the Joint Genome Institute. We demonstrate that comparative proteogenomics approach leads to improved annotations even for these well-studied genomes, let alone for genomes with only automated annotations available. Recent proliferation of low-cost DNA sequencing techniques and metagenomics studies will soon lead to an explosive growth in the number of sequenced genomes and will turn manual annotations into a luxury that can be afforded for only a small fraction of newly sequenced genomes. We therefore argue that complementing DNA sequencing projects by comparative proteogenomics projects can be a viable alternative approach to improve both genomic and proteomic annotations.
